elliot Servais to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications elliot Servais has written about Xenograft Model Antitumor Assays.
Connection Strength
0.388
-
Servais EL, Colovos C, Kachala SS, Adusumilli PS. Pre-clinical mouse models of primary and metastatic pleural cancers of the lung and breast and the use of bioluminescent imaging to monitor pleural tumor burden. Curr Protoc Pharmacol. 2011 Sep; Chapter 14:Unit14.21.
Score: 0.360
-
Adusumilli PS, Cherkassky L, Villena-Vargas J, Colovos C, Servais E, Plotkin J, Jones DR, Sadelain M. Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity. Sci Transl Med. 2014 Nov 05; 6(261):261ra151.
Score: 0.028